Amgen 2002 Annual Report Download - page 13

Download and view the complete annual report

Please find page 13 of the 2002 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 72

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72

For more than two decades, Amgen has helped lead
a revolution in human therapeutics, one grounded in
science, powered by new technologies, and conducted
at the molecular level.
Amgen has now grown into the largest independent
company operating in the biotechnology industry, with
integrated capabilities in the discovery, develop-
ment, and commercialization of human therapeutics.
Amgen products are used in markets around the world,
manufactured in facilities that have earned Amgen a track
record for quality unmatched in the industry.
But the achievement of Amgen’s greatest ambition still
lies ahead. For the company is now intent on building an
organization that combines the scientific knowledge, the
collaborative process, and the human spirit necessary to
become the best human therapeutics company.